About The Report
Exosomes Diagnostic and Therapeutic Market Growth Outlook 2025 to 2035
The exosomes diagnostic and therapeutic market is expanding steadily. Growth is being driven by advancements in molecular biology, rising focus on precision medicine, and increasing clinical research exploring exosome-based biomarkers. Current market dynamics are characterized by rapid technological integration, growing application of exosome analysis in oncology and neurology, and expanding collaborations between biotechnology firms and research institutions.
Regulatory agencies are emphasizing standardized protocols to ensure reproducibility and clinical reliability, strengthening market confidence. The future outlook remains positive as innovations in exosome isolation, purification, and quantification technologies enhance diagnostic accuracy and therapeutic potential.
Increasing healthcare investments and the growing shift toward non-invasive testing are supporting broader adoption across clinical and research settings Market growth rationale is supported by the rising need for early disease detection tools, therapeutic delivery platforms, and expanding translational research that bridges laboratory findings with clinical implementation, ensuring consistent revenue generation and long-term market sustainability.
Quick Stats for Exosomes Diagnostic and Therapeutic Market
- Exosomes Diagnostic and Therapeutic Market Industry Value (2025): USD 96.6 million
- Exosomes Diagnostic and Therapeutic Market Forecast Value (2035): USD 230.8 million
- Exosomes Diagnostic and Therapeutic Market Forecast CAGR: 9.1%
- Leading Segment in Exosomes Diagnostic and Therapeutic Market in 2025: Reagents And Kits (47.3%)
- Key Growth Region in Exosomes Diagnostic and Therapeutic Market: North America, Asia-Pacific, Europe
- Top Key Players in Exosomes Diagnostic and Therapeutic Market: Thermo Fisher Scientific, NanoSomix, NX Pharmagen, Malvern Instruments, Capricor Therapeutic, Exosome Diagnostics, Exiqon A/S, System Biosciences, Exosome Sciences, Aegle Therapeutic, AMS Biotechnology, Miltenyi Biotec, Codiak BioSciences Inc., Lonza Group (HansaBioMed Life Sciences Ltd.), AcouSort AB, Aethlon Medical, Inc., AGC Biologics, Anjarium Biosciences AG, Aruna Bio, Brexogen, Cells for Cells, Ciloa, ConvEyXO, Others
| Metric | Value |
|---|---|
| Exosomes Diagnostic and Therapeutic Market Estimated Value in (2025 E) | USD 96.6 million |
| Exosomes Diagnostic and Therapeutic Market Forecast Value in (2035 F) | USD 230.8 million |
| Forecast CAGR (2025 to 2035) | 9.1% |
Segmental Analysis
The market is segmented by Product, Application, and End User and region. By Product, the market is divided into Reagents And Kits, Instruments, and Software. In terms of Application, the market is classified into Diagnostic and Therapeutic. Based on End User, the market is segmented into Hospitals, Cancer Institutes, Diagnostic Centers, and Others.
Regionally, the market is classified into North America, Latin America, Western Europe, Eastern Europe, Balkan & Baltic Countries, Russia & Belarus, Central Asia, East Asia, South Asia & Pacific, and the Middle East & Africa.
Insights into the Product Segment
The reagents and kits segment, holding 47.3% of the product category, has emerged as the dominant segment due to its critical role in facilitating exosome isolation, characterization, and analysis. Its high share is attributed to the growing demand for standardized and ready-to-use solutions in both clinical and research laboratories.
Continuous technological refinement in kit sensitivity and specificity has improved reproducibility and reduced analysis time, enhancing laboratory efficiency. Market adoption is being reinforced by the increasing number of diagnostic studies leveraging exosome biomarkers for early disease detection and therapeutic monitoring.
Strategic partnerships between manufacturers and diagnostic developers have accelerated the commercialization of innovative reagent kits As research funding in exosome-based applications continues to rise, the reagents and kits segment is expected to maintain its leadership through sustained demand across academic, biopharmaceutical, and clinical institutions.
Insights into the Application Segment
The diagnostic segment, accounting for 58.6% of the application category, has maintained dominance owing to its widespread adoption in early disease detection, monitoring, and prognosis evaluation. The integration of exosome-based diagnostics into oncology, neurology, and cardiovascular testing frameworks has enhanced clinical utility and precision.
Demand has been strengthened by the growing focus on liquid biopsy technologies that enable non-invasive screening with high biomarker sensitivity. Healthcare institutions and research centers are increasingly relying on exosome diagnostics for personalized treatment planning and disease progression tracking.
Continuous development of novel biomarkers and analytical platforms is improving diagnostic reliability and cost-efficiency With increasing validation from clinical trials and supportive regulatory pathways, the diagnostic segment is projected to experience sustained growth and remain central to the future of exosome-based medical applications.
Insights into the End User Segment
The hospitals segment, representing 42.8% of the end user category, leads the market due to its established infrastructure, access to advanced diagnostic technologies, and high patient throughput. Hospitals play a pivotal role in early adoption of exosome-based diagnostic and therapeutic solutions through integration into oncology and precision medicine programs.
The segment’s growth is supported by the presence of multidisciplinary diagnostic facilities and partnerships with biotech firms for pilot clinical implementations. Continuous training of healthcare professionals in exosome technology and integration of diagnostic testing into routine clinical workflows have reinforced adoption.
Additionally, increasing investment in hospital-based research and translational programs has expanded the clinical utility of exosome diagnostics Over the forecast period, the hospital segment is expected to maintain its leadership, driven by continuous infrastructure upgrades and growing patient preference for institution-based advanced diagnostic services.
Emerging Trends and Opportunities in the Exosomes Diagnostic and Therapeutic Market
The healthcare sector is facing pressure to reduce the prices of healthcare services to increase their accessibility among the rising patient population. In this regard, laboratories are adopting solutions that are integrated with informatics. This helps boost productivity with the help of available resources.
Manufacturers are taking an opportunistic approach by offering such healthcare facilities with additional services and support in terms of diagnostic test products. Consequently, contributes to market growth.
Key players are also capitalizing on the growing demand for non-invasive tests to diagnose cancer. For this, they continue to maintain partnerships with academic institutes to develop novel non-invasive diagnostics.
Category-wise Exosomes Diagnostic and Therapeutic Market Analysis
Exosomes are Excessively Used for Diagnostic Purposes
| Leading Application | Diagnostics |
|---|---|
| Value Share (2025) | 68.0% |
Based on application, the exosome-based diagnostics segment acquired a massive value share of 68% in 2025. Significant use of exosomes for diagnostic purposes can be attributed to their effective delivery of specific disease cells like nucleic acids and proteins. Exosome diagnostic tests are presently being developed for several diseases like infectious diseases, cancer, and neurological disorders.
Instruments Segment to Capture a Sizeable Market Share
| Leading Product Type | Instruments |
|---|---|
| Value Share (2025) | 25.0% |
By product type, the instruments segment accounts for a prominent share of 25% in the exosomes diagnostic and therapeutic market. The segment is driven by rapid advancements in research and development activities in the healthcare sector. Growth in the count of manufacturers providing instruments for diagnostic and therapeutic is also propelling the segment expansion.
Global Exosomes Diagnostic and Therapeutic Sales Analysis by Country
| Countries | Forecast CAGR (2025 to 2035) |
|---|---|
| The United States | 4.50% |
| Canada | 5.0% |
| Germany | 3.80% |
| China | 10.0% |
| India | 9.50% |
Research Groups in the United States Make Breakthroughs in Cancer Diagnosis with Exosomes
Market players are exploiting the potential for the exosome diagnostic and therapeutic industry in the United States, which is estimated to grow at 4.5% CAGR over the forecast period. Exosomes have been receiving significant traction over the past few years due to their remarkable therapeutic possibilities.
They can be harnessed for focused delivery of therapeutic agents, like nucleic acids, proteins, and pharmaceuticals, nucleic acids, throughout biological barriers. This attribute holds a lot of potential in precision medicine applications, especially in cancer therapy.
Numerous cutting-edge technologies and the latest strategies have been developed to harness the capability of exosomes to enhance the efficiency and precision of cancer detection. These approaches can revolutionize cancer diagnostics, offering non-invasive, more precise, and early detection methods.
Liquid biopsies are one such disruptive strategy in cancer treatment, which uses non-invasive collection and investigation of exosomes from body fluids like urine, blood, and saliva.
The rapid increase in cancer patients and surging funding for cancer-related research are expected to continue supporting the exosome diagnostic and therapeutic industry in the United States.
Researchers in Canada Explore Urinary Exosomes for Disease Diagnosis
Adoption of exosomes diagnostic and therapeutic in Canada is projected to surge at a CAGR of 5% through 2035. Growth of this industry is increasing as researchers are trying to understand the connection between kidney function and disorders and urinary exosomes since exosomes carry cargo across kidney cells.
The availability, non-invasive nature, and ease of sample collection of urinary exosomes make them remarkable. Non-invasive exosomes offer a cost-effective way to uncover disease causes and therapeutic targets owing to their prognostic and diagnostic sensitivity. Additionally, non-invasive biomarkers have more patient and clinical adoption than their invasive counterparts.
Conveniently distributable and cost-effective distributable urinary indicators are clinically accessible. These factors contribute to the growth of the exosomes diagnostic and therapeutic market.
Advanced Diagnostic Assays in Germany Encourage the Exosomes Diagnostic and Therapeutic Industry
The scope of exosomes diagnostic and therapeutic in Germany is estimated to expand at a CAGR of 3.80% over the next 10 years. The industry is expected to be propelled by the increasing count of research activities with a focus on applications of exosomes to access the therapeutic effects of stem cells within the country.
Growing demand for advanced diagnostic assays as well as the increasing incidence of cancer in Germany are contributing to exosomes diagnostic and therapeutic market growth. Certain common factors that are compelling growth in the industry include advancements in healthcare systems and surging funding for research and development in Germany.
Increasing Cases of Diseases in India Draws Investors’ Interest
Investments in the Indian market are projected to rise at a CAGR of 9.5% in the following decade. Increasing cases of diseases like infectious disorders, cancer, and neurological diseases in India are raising the demand for more effective treatment and diagnostic tools offered by exosomes.
Ongoing technological advancements like proteomic analysis and high-throughput techniques are facilitating the characterization and identification of exosomes. Along with this, technological progress is helping in the development of diagnostic therapies and tools based on exosomes.
Surging investments from government agencies, private investors, and pharmaceutical firms are promoting research and growth in exosome diagnostics and therapeutics. With improving regulatory acceptance for exosome-based products, the market is set for significant expansion.
China to Observe Robust Growth Over the Next Decade as Non-invasive Testing Rises in Acceptability
Demand for exosome diagnostic and therapeutic in China is expected to rise at a CAGR of 10% over the forecast period. The market is driven by an increase in clinically researched and perceived applications of exosomes as smart nano-platforms for therapy and diagnosis in the country. Additionally, market players in China are increasing their efforts to exhibit the utility of exosomes in non-invasive testing to accelerate its adoption.
Competitive Landscape
The exosome diagnostic and therapeutic industry is experiencing a high level of competition, thanks to the growing count of companies manufacturing exosome-based products. All known companies in the market are covered below. Along with the companies, the technology that they are working on is also described. The following companies may or may not be working with any regulatory agencies, however, many of them do.
AcouSort AB
It is a Swedish firm that is introducing a revolutionary acoustofluidic technology and working on exosome-based diagnostics. The European Innovation Council (EIC) rewarded AcouSort and its project partners with a total of USD 2.5 million to create acoustofluidic thin-film actuated chip to separate exosomes from blood.
Aethlon Medical, Inc.
It is a United States-based company that focuses on addressing the unmet requirements in the global health and biodefense industry. The firm began its tumor-derived exosome research when the medical community held a view that exosomes are cellular debris.
Fast-forward to the present, a therapeutic to attend to tumor-derived exosomes presents a significant gap in cancer care. Aethlon has shown that Hemopurifier®’s affinity mechanism can detect tumor-derived exosomes behind various forms of cancer, like ovarian, breast, and metastatic melanoma.
AGC Biologics
AGC Biologics came into a service agreement with Japan’s Jikei University in April 2025. This agreement states that AGC Biologics is going to assume a feasibility study and technology transfer for a drug to cure idiopathic pulmonary fibrosis (IPF). Specifically, the ACG scientists are going to focus on recognizing the viability of developing a sample for an exosome-based treatment.
Aruna Bio
The company is leveraging the natural abilities of neural exosomes to pass the blood-brain barrier and elevate the body’s anti-inflammatory, protective, and self-repair mechanisms for neurodegenerative disorders treatment.
Latest Developments in the Exosomes Diagnostic and Therapeutic Market
- Thermo Fisher Scientific introduced the Thermo Scientific KingFisher Apex Purification System in April 2025. This system is a high-throughput sample purification tool that is developed for scientists who want to automate the extraction of RNA, DNA, cells, and protein from an array of sample types. The system helps enhance research productivity and propel discoveries by automating and simplifying the sample preparation workflow.
- In February 2025, Bio-Techne Corporation made public its agreement with Thermo Fisher Scientific. Under this agreement, the latter company will be helping a Bio-Techne brand called Exosome Diagnostics to develop and commercialize the ExoTRU kidney transplant rejection test.
Key Coverage in the Global Exosomes Diagnostic and Therapeutic Market Research Report
- Adjacent Study of Exosome Technologies Market, Exosome Biomarkers Market, Exosome Isolation Kits Market, Exosome Analysis Market, and Exosome Therapeutics Market
- Market Dynamics of Exosome Isolation Kits are Mentioned
Key Players in the Exosomes Diagnostic and Therapeutic Market
- Thermo Fisher Scientific
- NanoSomix
- NX Pharmagen
- Malvern Instruments
- Capricor Therapeutic
- Exosome Diagnostics
- Exiqon A/S
- System Biosciences
- Exosome Sciences
- Aegle Therapeutic
- AMS Biotechnology
- Miltenyi Biotec
- Codiak BioSciences Inc.
- Lonza Group (HansaBioMed Life Sciences Ltd.)
- AcouSort AB
- Aethlon Medical, Inc.
- AGC Biologics
- Anjarium Biosciences AG
- Aruna Bio
- Brexogen
- Capricor Therapeutics
- Cells for Cells
- Ciloa
- ConvEyXO
- Others
Exosomes Diagnostic and Therapeutic Market Research by Categories
By Products for Exosomes Diagnostic and Therapeutic are as follows:
- Instruments
- Software
- Reagents and Kits
The Market is Bifurcated Based on Applications as:
- Diagnostics
- Therapeutic
Key End Users of Exosomes Diagnostic and Therapeutic are:
- Hospitals
- Cancer Institutes
- Diagnostic Centers
- Others
Different Markets for Exosomes Diagnostic and Therapeutic are:
- North America
- Europe
- Asia Pacific
- Middle East and Africa
- Latin America
Frequently Asked Questions
How big is the exosomes diagnostic and therapeutic market in 2025?
The global exosomes diagnostic and therapeutic market is estimated to be valued at USD 96.6 million in 2025.
What will be the size of exosomes diagnostic and therapeutic market in 2035?
The market size for the exosomes diagnostic and therapeutic market is projected to reach USD 230.8 million by 2035.
How much will be the exosomes diagnostic and therapeutic market growth between 2025 and 2035?
The exosomes diagnostic and therapeutic market is expected to grow at a 9.1% CAGR between 2025 and 2035.
What are the key product types in the exosomes diagnostic and therapeutic market?
The key product types in exosomes diagnostic and therapeutic market are reagents and kits, instruments and software.
Which application segment to contribute significant share in the exosomes diagnostic and therapeutic market in 2025?
In terms of application, diagnostic segment to command 58.6% share in the exosomes diagnostic and therapeutic market in 2025.
Table of Content
- Executive Summary
- Global Market Outlook
- Demand to side Trends
- Supply to side Trends
- Technology Roadmap Analysis
- Analysis and Recommendations
- Market Overview
- Market Coverage / Taxonomy
- Market Definition / Scope / Limitations
- Market Background
- Market Dynamics
- Drivers
- Restraints
- Opportunity
- Trends
- Scenario Forecast
- Demand in Optimistic Scenario
- Demand in Likely Scenario
- Demand in Conservative Scenario
- Opportunity Map Analysis
- Product Life Cycle Analysis
- Supply Chain Analysis
- Investment Feasibility Matrix
- Value Chain Analysis
- PESTLE and Porter’s Analysis
- Regulatory Landscape
- Regional Parent Market Outlook
- Production and Consumption Statistics
- Import and Export Statistics
- Market Dynamics
- Global Market Analysis 2020 to 2025 and Forecast, 2025 to 2035
- Historical Market Size Value (USD Million) Analysis, 2020 to 2025
- Current and Future Market Size Value (USD Million) Projections, 2025 to 2035
- Y to o to Y Growth Trend Analysis
- Absolute $ Opportunity Analysis
- Global Market Pricing Analysis 2020 to 2025 and Forecast 2025 to 2035
- Global Market Analysis 2020 to 2025 and Forecast 2025 to 2035, By Product
- Introduction / Key Findings
- Historical Market Size Value (USD Million) Analysis By Product , 2020 to 2025
- Current and Future Market Size Value (USD Million) Analysis and Forecast By Product , 2025 to 2035
- Reagents And Kits
- Instruments
- Software
- Y to o to Y Growth Trend Analysis By Product , 2020 to 2025
- Absolute $ Opportunity Analysis By Product , 2025 to 2035
- Global Market Analysis 2020 to 2025 and Forecast 2025 to 2035, By Application
- Introduction / Key Findings
- Historical Market Size Value (USD Million) Analysis By Application, 2020 to 2025
- Current and Future Market Size Value (USD Million) Analysis and Forecast By Application, 2025 to 2035
- Diagnostic
- Therapeutic
- Y to o to Y Growth Trend Analysis By Application, 2020 to 2025
- Absolute $ Opportunity Analysis By Application, 2025 to 2035
- Global Market Analysis 2020 to 2025 and Forecast 2025 to 2035, By End User
- Introduction / Key Findings
- Historical Market Size Value (USD Million) Analysis By End User, 2020 to 2025
- Current and Future Market Size Value (USD Million) Analysis and Forecast By End User, 2025 to 2035
- Hospitals
- Cancer Institutes
- Diagnostic Centers
- Others
- Y to o to Y Growth Trend Analysis By End User, 2020 to 2025
- Absolute $ Opportunity Analysis By End User, 2025 to 2035
- Global Market Analysis 2020 to 2025 and Forecast 2025 to 2035, By Region
- Introduction
- Historical Market Size Value (USD Million) Analysis By Region, 2020 to 2025
- Current Market Size Value (USD Million) Analysis and Forecast By Region, 2025 to 2035
- North America
- Latin America
- Western Europe
- Eastern Europe
- East Asia
- South Asia and Pacific
- Middle East & Africa
- Market Attractiveness Analysis By Region
- North America Market Analysis 2020 to 2025 and Forecast 2025 to 2035, By Country
- Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2020 to 2025
- Market Size Value (USD Million) Forecast By Market Taxonomy, 2025 to 2035
- By Country
- USA
- Canada
- Mexico
- By Product
- By Application
- By End User
- By Country
- Market Attractiveness Analysis
- By Country
- By Product
- By Application
- By End User
- Key Takeaways
- Latin America Market Analysis 2020 to 2025 and Forecast 2025 to 2035, By Country
- Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2020 to 2025
- Market Size Value (USD Million) Forecast By Market Taxonomy, 2025 to 2035
- By Country
- Brazil
- Chile
- Rest of Latin America
- By Product
- By Application
- By End User
- By Country
- Market Attractiveness Analysis
- By Country
- By Product
- By Application
- By End User
- Key Takeaways
- Western Europe Market Analysis 2020 to 2025 and Forecast 2025 to 2035, By Country
- Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2020 to 2025
- Market Size Value (USD Million) Forecast By Market Taxonomy, 2025 to 2035
- By Country
- Germany
- UK
- Italy
- Spain
- France
- Nordic
- BENELUX
- Rest of Western Europe
- By Product
- By Application
- By End User
- By Country
- Market Attractiveness Analysis
- By Country
- By Product
- By Application
- By End User
- Key Takeaways
- Eastern Europe Market Analysis 2020 to 2025 and Forecast 2025 to 2035, By Country
- Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2020 to 2025
- Market Size Value (USD Million) Forecast By Market Taxonomy, 2025 to 2035
- By Country
- Russia
- Poland
- Hungary
- Balkan & Baltic
- Rest of Eastern Europe
- By Product
- By Application
- By End User
- By Country
- Market Attractiveness Analysis
- By Country
- By Product
- By Application
- By End User
- Key Takeaways
- East Asia Market Analysis 2020 to 2025 and Forecast 2025 to 2035, By Country
- Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2020 to 2025
- Market Size Value (USD Million) Forecast By Market Taxonomy, 2025 to 2035
- By Country
- China
- Japan
- South Korea
- By Product
- By Application
- By End User
- By Country
- Market Attractiveness Analysis
- By Country
- By Product
- By Application
- By End User
- Key Takeaways
- South Asia and Pacific Market Analysis 2020 to 2025 and Forecast 2025 to 2035, By Country
- Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2020 to 2025
- Market Size Value (USD Million) Forecast By Market Taxonomy, 2025 to 2035
- By Country
- India
- ASEAN
- Australia & New Zealand
- Rest of South Asia and Pacific
- By Product
- By Application
- By End User
- By Country
- Market Attractiveness Analysis
- By Country
- By Product
- By Application
- By End User
- Key Takeaways
- Middle East & Africa Market Analysis 2020 to 2025 and Forecast 2025 to 2035, By Country
- Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2020 to 2025
- Market Size Value (USD Million) Forecast By Market Taxonomy, 2025 to 2035
- By Country
- Kingdom of Saudi Arabia
- Other GCC Countries
- Turkiye
- South Africa
- Other African Union
- Rest of Middle East & Africa
- By Product
- By Application
- By End User
- By Country
- Market Attractiveness Analysis
- By Country
- By Product
- By Application
- By End User
- Key Takeaways
- Key Countries Market Analysis
- USA
- Pricing Analysis
- Market Share Analysis, 2025
- By Product
- By Application
- By End User
- Canada
- Pricing Analysis
- Market Share Analysis, 2025
- By Product
- By Application
- By End User
- Mexico
- Pricing Analysis
- Market Share Analysis, 2025
- By Product
- By Application
- By End User
- Brazil
- Pricing Analysis
- Market Share Analysis, 2025
- By Product
- By Application
- By End User
- Chile
- Pricing Analysis
- Market Share Analysis, 2025
- By Product
- By Application
- By End User
- Germany
- Pricing Analysis
- Market Share Analysis, 2025
- By Product
- By Application
- By End User
- UK
- Pricing Analysis
- Market Share Analysis, 2025
- By Product
- By Application
- By End User
- Italy
- Pricing Analysis
- Market Share Analysis, 2025
- By Product
- By Application
- By End User
- Spain
- Pricing Analysis
- Market Share Analysis, 2025
- By Product
- By Application
- By End User
- France
- Pricing Analysis
- Market Share Analysis, 2025
- By Product
- By Application
- By End User
- India
- Pricing Analysis
- Market Share Analysis, 2025
- By Product
- By Application
- By End User
- ASEAN
- Pricing Analysis
- Market Share Analysis, 2025
- By Product
- By Application
- By End User
- Australia & New Zealand
- Pricing Analysis
- Market Share Analysis, 2025
- By Product
- By Application
- By End User
- China
- Pricing Analysis
- Market Share Analysis, 2025
- By Product
- By Application
- By End User
- Japan
- Pricing Analysis
- Market Share Analysis, 2025
- By Product
- By Application
- By End User
- South Korea
- Pricing Analysis
- Market Share Analysis, 2025
- By Product
- By Application
- By End User
- Russia
- Pricing Analysis
- Market Share Analysis, 2025
- By Product
- By Application
- By End User
- Poland
- Pricing Analysis
- Market Share Analysis, 2025
- By Product
- By Application
- By End User
- Hungary
- Pricing Analysis
- Market Share Analysis, 2025
- By Product
- By Application
- By End User
- Kingdom of Saudi Arabia
- Pricing Analysis
- Market Share Analysis, 2025
- By Product
- By Application
- By End User
- Turkiye
- Pricing Analysis
- Market Share Analysis, 2025
- By Product
- By Application
- By End User
- South Africa
- Pricing Analysis
- Market Share Analysis, 2025
- By Product
- By Application
- By End User
- USA
- Market Structure Analysis
- Competition Dashboard
- Competition Benchmarking
- Market Share Analysis of Top Players
- By Regional
- By Product
- By Application
- By End User
- Competition Analysis
- Competition Deep Dive
- Thermo Fisher Scientific
- Overview
- Product Portfolio
- Profitability by Market Segments (Product/Age /Sales Channel/Region)
- Sales Footprint
- Strategy Overview
- Marketing Strategy
- Product Strategy
- Channel Strategy
- NanoSomix
- NX Pharmagen
- Malvern Instruments
- Capricor Therapeutic
- Exosome Diagnostics
- Exiqon A/S
- System Biosciences
- Exosome Sciences
- Aegle Therapeutic
- AMS Biotechnology
- Miltenyi Biotec
- Codiak BioSciences Inc.
- Lonza Group (HansaBioMed Life Sciences Ltd.)
- AcouSort AB
- Aethlon Medical, Inc.
- AGC Biologics
- Anjarium Biosciences AG
- Aruna Bio
- Brexogen
- Thermo Fisher Scientific
- Competition Deep Dive
- Assumptions & Acronyms Used
- Research Methodology
List of Tables
- Table 1: Global Market Value (USD Million) Forecast by Region, 2020 to 2035
- Table 2: Global Market Value (USD Million) Forecast by Product , 2020 to 2035
- Table 3: Global Market Value (USD Million) Forecast by Application, 2020 to 2035
- Table 4: Global Market Value (USD Million) Forecast by End User, 2020 to 2035
- Table 5: North America Market Value (USD Million) Forecast by Country, 2020 to 2035
- Table 6: North America Market Value (USD Million) Forecast by Product , 2020 to 2035
- Table 7: North America Market Value (USD Million) Forecast by Application, 2020 to 2035
- Table 8: North America Market Value (USD Million) Forecast by End User, 2020 to 2035
- Table 9: Latin America Market Value (USD Million) Forecast by Country, 2020 to 2035
- Table 10: Latin America Market Value (USD Million) Forecast by Product , 2020 to 2035
- Table 11: Latin America Market Value (USD Million) Forecast by Application, 2020 to 2035
- Table 12: Latin America Market Value (USD Million) Forecast by End User, 2020 to 2035
- Table 13: Western Europe Market Value (USD Million) Forecast by Country, 2020 to 2035
- Table 14: Western Europe Market Value (USD Million) Forecast by Product , 2020 to 2035
- Table 15: Western Europe Market Value (USD Million) Forecast by Application, 2020 to 2035
- Table 16: Western Europe Market Value (USD Million) Forecast by End User, 2020 to 2035
- Table 17: Eastern Europe Market Value (USD Million) Forecast by Country, 2020 to 2035
- Table 18: Eastern Europe Market Value (USD Million) Forecast by Product , 2020 to 2035
- Table 19: Eastern Europe Market Value (USD Million) Forecast by Application, 2020 to 2035
- Table 20: Eastern Europe Market Value (USD Million) Forecast by End User, 2020 to 2035
- Table 21: East Asia Market Value (USD Million) Forecast by Country, 2020 to 2035
- Table 22: East Asia Market Value (USD Million) Forecast by Product , 2020 to 2035
- Table 23: East Asia Market Value (USD Million) Forecast by Application, 2020 to 2035
- Table 24: East Asia Market Value (USD Million) Forecast by End User, 2020 to 2035
- Table 25: South Asia and Pacific Market Value (USD Million) Forecast by Country, 2020 to 2035
- Table 26: South Asia and Pacific Market Value (USD Million) Forecast by Product , 2020 to 2035
- Table 27: South Asia and Pacific Market Value (USD Million) Forecast by Application, 2020 to 2035
- Table 28: South Asia and Pacific Market Value (USD Million) Forecast by End User, 2020 to 2035
- Table 29: Middle East & Africa Market Value (USD Million) Forecast by Country, 2020 to 2035
- Table 30: Middle East & Africa Market Value (USD Million) Forecast by Product , 2020 to 2035
- Table 31: Middle East & Africa Market Value (USD Million) Forecast by Application, 2020 to 2035
- Table 32: Middle East & Africa Market Value (USD Million) Forecast by End User, 2020 to 2035
List of Figures
- Figure 1: Global Market Pricing Analysis
- Figure 2: Global Market Value (USD Million) Forecast 2020-2035
- Figure 3: Global Market Value Share and BPS Analysis by Product , 2025 and 2035
- Figure 4: Global Market Y to o to Y Growth Comparison by Product , 2025-2035
- Figure 5: Global Market Attractiveness Analysis by Product
- Figure 6: Global Market Value Share and BPS Analysis by Application, 2025 and 2035
- Figure 7: Global Market Y to o to Y Growth Comparison by Application, 2025-2035
- Figure 8: Global Market Attractiveness Analysis by Application
- Figure 9: Global Market Value Share and BPS Analysis by End User, 2025 and 2035
- Figure 10: Global Market Y to o to Y Growth Comparison by End User, 2025-2035
- Figure 11: Global Market Attractiveness Analysis by End User
- Figure 12: Global Market Value (USD Million) Share and BPS Analysis by Region, 2025 and 2035
- Figure 13: Global Market Y to o to Y Growth Comparison by Region, 2025-2035
- Figure 14: Global Market Attractiveness Analysis by Region
- Figure 15: North America Market Incremental Dollar Opportunity, 2025-2035
- Figure 16: Latin America Market Incremental Dollar Opportunity, 2025-2035
- Figure 17: Western Europe Market Incremental Dollar Opportunity, 2025-2035
- Figure 18: Eastern Europe Market Incremental Dollar Opportunity, 2025-2035
- Figure 19: East Asia Market Incremental Dollar Opportunity, 2025-2035
- Figure 20: South Asia and Pacific Market Incremental Dollar Opportunity, 2025-2035
- Figure 21: Middle East & Africa Market Incremental Dollar Opportunity, 2025-2035
- Figure 22: North America Market Value Share and BPS Analysis by Country, 2025 and 2035
- Figure 23: North America Market Value Share and BPS Analysis by Product , 2025 and 2035
- Figure 24: North America Market Y to o to Y Growth Comparison by Product , 2025-2035
- Figure 25: North America Market Attractiveness Analysis by Product
- Figure 26: North America Market Value Share and BPS Analysis by Application, 2025 and 2035
- Figure 27: North America Market Y to o to Y Growth Comparison by Application, 2025-2035
- Figure 28: North America Market Attractiveness Analysis by Application
- Figure 29: North America Market Value Share and BPS Analysis by End User, 2025 and 2035
- Figure 30: North America Market Y to o to Y Growth Comparison by End User, 2025-2035
- Figure 31: North America Market Attractiveness Analysis by End User
- Figure 32: Latin America Market Value Share and BPS Analysis by Country, 2025 and 2035
- Figure 33: Latin America Market Value Share and BPS Analysis by Product , 2025 and 2035
- Figure 34: Latin America Market Y to o to Y Growth Comparison by Product , 2025-2035
- Figure 35: Latin America Market Attractiveness Analysis by Product
- Figure 36: Latin America Market Value Share and BPS Analysis by Application, 2025 and 2035
- Figure 37: Latin America Market Y to o to Y Growth Comparison by Application, 2025-2035
- Figure 38: Latin America Market Attractiveness Analysis by Application
- Figure 39: Latin America Market Value Share and BPS Analysis by End User, 2025 and 2035
- Figure 40: Latin America Market Y to o to Y Growth Comparison by End User, 2025-2035
- Figure 41: Latin America Market Attractiveness Analysis by End User
- Figure 42: Western Europe Market Value Share and BPS Analysis by Country, 2025 and 2035
- Figure 43: Western Europe Market Value Share and BPS Analysis by Product , 2025 and 2035
- Figure 44: Western Europe Market Y to o to Y Growth Comparison by Product , 2025-2035
- Figure 45: Western Europe Market Attractiveness Analysis by Product
- Figure 46: Western Europe Market Value Share and BPS Analysis by Application, 2025 and 2035
- Figure 47: Western Europe Market Y to o to Y Growth Comparison by Application, 2025-2035
- Figure 48: Western Europe Market Attractiveness Analysis by Application
- Figure 49: Western Europe Market Value Share and BPS Analysis by End User, 2025 and 2035
- Figure 50: Western Europe Market Y to o to Y Growth Comparison by End User, 2025-2035
- Figure 51: Western Europe Market Attractiveness Analysis by End User
- Figure 52: Eastern Europe Market Value Share and BPS Analysis by Country, 2025 and 2035
- Figure 53: Eastern Europe Market Value Share and BPS Analysis by Product , 2025 and 2035
- Figure 54: Eastern Europe Market Y to o to Y Growth Comparison by Product , 2025-2035
- Figure 55: Eastern Europe Market Attractiveness Analysis by Product
- Figure 56: Eastern Europe Market Value Share and BPS Analysis by Application, 2025 and 2035
- Figure 57: Eastern Europe Market Y to o to Y Growth Comparison by Application, 2025-2035
- Figure 58: Eastern Europe Market Attractiveness Analysis by Application
- Figure 59: Eastern Europe Market Value Share and BPS Analysis by End User, 2025 and 2035
- Figure 60: Eastern Europe Market Y to o to Y Growth Comparison by End User, 2025-2035
- Figure 61: Eastern Europe Market Attractiveness Analysis by End User
- Figure 62: East Asia Market Value Share and BPS Analysis by Country, 2025 and 2035
- Figure 63: East Asia Market Value Share and BPS Analysis by Product , 2025 and 2035
- Figure 64: East Asia Market Y to o to Y Growth Comparison by Product , 2025-2035
- Figure 65: East Asia Market Attractiveness Analysis by Product
- Figure 66: East Asia Market Value Share and BPS Analysis by Application, 2025 and 2035
- Figure 67: East Asia Market Y to o to Y Growth Comparison by Application, 2025-2035
- Figure 68: East Asia Market Attractiveness Analysis by Application
- Figure 69: East Asia Market Value Share and BPS Analysis by End User, 2025 and 2035
- Figure 70: East Asia Market Y to o to Y Growth Comparison by End User, 2025-2035
- Figure 71: East Asia Market Attractiveness Analysis by End User
- Figure 72: South Asia and Pacific Market Value Share and BPS Analysis by Country, 2025 and 2035
- Figure 73: South Asia and Pacific Market Value Share and BPS Analysis by Product , 2025 and 2035
- Figure 74: South Asia and Pacific Market Y to o to Y Growth Comparison by Product , 2025-2035
- Figure 75: South Asia and Pacific Market Attractiveness Analysis by Product
- Figure 76: South Asia and Pacific Market Value Share and BPS Analysis by Application, 2025 and 2035
- Figure 77: South Asia and Pacific Market Y to o to Y Growth Comparison by Application, 2025-2035
- Figure 78: South Asia and Pacific Market Attractiveness Analysis by Application
- Figure 79: South Asia and Pacific Market Value Share and BPS Analysis by End User, 2025 and 2035
- Figure 80: South Asia and Pacific Market Y to o to Y Growth Comparison by End User, 2025-2035
- Figure 81: South Asia and Pacific Market Attractiveness Analysis by End User
- Figure 82: Middle East & Africa Market Value Share and BPS Analysis by Country, 2025 and 2035
- Figure 83: Middle East & Africa Market Value Share and BPS Analysis by Product , 2025 and 2035
- Figure 84: Middle East & Africa Market Y to o to Y Growth Comparison by Product , 2025-2035
- Figure 85: Middle East & Africa Market Attractiveness Analysis by Product
- Figure 86: Middle East & Africa Market Value Share and BPS Analysis by Application, 2025 and 2035
- Figure 87: Middle East & Africa Market Y to o to Y Growth Comparison by Application, 2025-2035
- Figure 88: Middle East & Africa Market Attractiveness Analysis by Application
- Figure 89: Middle East & Africa Market Value Share and BPS Analysis by End User, 2025 and 2035
- Figure 90: Middle East & Africa Market Y to o to Y Growth Comparison by End User, 2025-2035
- Figure 91: Middle East & Africa Market Attractiveness Analysis by End User
- Figure 92: Global Market - Tier Structure Analysis
- Figure 93: Global Market - Company Share Analysis
Our Research Products
The "Full Research Suite" delivers actionable market intel, deep dives on markets or technologies, so clients act faster, cut risk, and unlock growth.
The Leaderboard benchmarks and ranks top vendors, classifying them as Established Leaders, Leading Challengers, or Disruptors & Challengers.
Locates where complements amplify value and substitutes erode it, forecasting net impact by horizon
We deliver granular, decision-grade intel: market sizing, 5-year forecasts, pricing, adoption, usage, revenue, and operational KPIs—plus competitor tracking, regulation, and value chains—across 60 countries broadly.
Spot the shifts before they hit your P&L. We track inflection points, adoption curves, pricing moves, and ecosystem plays to show where demand is heading, why it is changing, and what to do next across high-growth markets and disruptive tech
Real-time reads of user behavior. We track shifting priorities, perceptions of today’s and next-gen services, and provider experience, then pace how fast tech moves from trial to adoption, blending buyer, consumer, and channel inputs with social signals (#WhySwitch, #UX).
Partner with our analyst team to build a custom report designed around your business priorities. From analysing market trends to assessing competitors or crafting bespoke datasets, we tailor insights to your needs.
Supplier Intelligence
Discovery & Profiling
Capacity & Footprint
Performance & Risk
Compliance & Governance
Commercial Readiness
Who Supplies Whom
Scorecards & Shortlists
Playbooks & Docs
Category Intelligence
Definition & Scope
Demand & Use Cases
Cost Drivers
Market Structure
Supply Chain Map
Trade & Policy
Operating Norms
Deliverables
Buyer Intelligence
Account Basics
Spend & Scope
Procurement Model
Vendor Requirements
Terms & Policies
Entry Strategy
Pain Points & Triggers
Outputs
Pricing Analysis
Benchmarks
Trends
Should-Cost
Indexation
Landed Cost
Commercial Terms
Deliverables
Brand Analysis
Positioning & Value Prop
Share & Presence
Customer Evidence
Go-to-Market
Digital & Reputation
Compliance & Trust
KPIs & Gaps
Outputs
Full Research Suite comprises of:
Market outlook & trends analysis
Interviews & case studies
Strategic recommendations
Vendor profiles & capabilities analysis
5-year forecasts
8 regions and 60+ country-level data splits
Market segment data splits
12 months of continuous data updates
DELIVERED AS:
PDF EXCEL ONLINE
